View Profile

koppula jayanthi

Pharmaceutical chemistry · SRI BALJI VIDYPEETH

https://researchid.co/jayanthi123
@52125010
55Google Scholar Citations
4Google Scholar h-index
2Google Scholar i10-index

Research Interests

Synthesis of Pharmaceutical Compounds, in silico studies, Molecular Dynamic Simulation, Microbiology, and Critical Literature Review. Antimicrobial Agents, Cancer Therapeutics, Central Nervous System (CNS) Disorders, Diabetes

Biography

I am Dr Jayanthi, an Associate Professor with a PhD in Pharmaceutical Chemistry. I have over 10 years of teaching and research experience, with expertise in synthetic chemistry and in silico studies. My research primarily focuses on antimicrobial and anticancer drug development, CNS disorders, and computational drug design. I have published more than 11 Scopus-indexed research papers. I have presented my work at several national and international scientific conferences. I am deeply passionate about advancing in pharmaceutical research and mentoring young scientists.Areas of Expertise: Synthesis of Pharmaceutical Compounds, in silico studies, Molecular Dynamic Simulation, Microbiology, and Critical Literature Review. Research Interests: Antimicrobial Agents, Cancer Therapeutics, Central Nervous System (CNS) Disorders, Diabetes,

Recent Google Scholar Publications

  1. Design and Synthesis of Benzylidene Phenylacetamide-based Derivatives as Potential Antibacterial Agents Targeting Staphylococcus Aureus Thymidylate Kinase
    2026
  2. DESIGN AND IN SILICO EVALUATION OF PHENOXY ACETAMIDE DERIVATIVES AS POTENTIAL ANTIDIABETIC AGENTS
    Int J App Pharm 17 (5), 159-167 , 2025, 2025
  3. Molecular docking insights into probiotics SAKACIN P and SAKACIN a as potential inhibitors of the COX-2 pathway for colon cancer therapy
    Int J App Pharm 17 (1), 153-160 , 2025, 2025 | Citations: 4.0
  4. Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: a novel approach to treat colon cancer through active targeting
    International journal of biological macromolecules 279, 135487 , 2024, 2024 | Citations: 20.0
  5. MOLECULAR DOCKING INSIGHTS INTO PROBIOTICS SAKACIN P AND SAKACIN A AS POTENTIAL INHIBITORS OF THE COX-2 PATHWAY FOR COLON CANCER THERAPY,
    International Journal of Applied Pharmaceutics 16 (4), 250-6 , 2024, 2024

Links